Companies: 10,795·Total market cap: $144.5T
Item 9 Labs Corp.

Item 9 Labs Corp.

INLBOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$70181
P/E Ratio
52W High$0.0001
52W Low$0.0001

Item 9 Labs Corp.(INLB)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · INLB · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-092021-092020-092019-092018-09
Revenue
Revenue$21.76M$21.94M$8.12M$4.93M$1.38M
Cost of Revenue$14.45M$13.32M$4.83M$2.56M$1.02M
Gross Profit$7.31M$8.61M$3.30M$2.38M$0.36M
Gross Margin %(computed)33.61%39.26%40.58%48.19%25.97%
Operating Expenses
R&D Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
G&A Expenses$17.02M$9.89M$5.52M$4.12M$0.39M
Total Operating Expenses$30.38M$14.21M$8.62M$6.76M$1.05M
Operating Income($23.07M)($5.60M)($5.33M)($4.38M)($0.69M)
Operating Margin %(computed)-106.01%-25.53%-65.58%-88.82%-50.28%
Interest Income$0.00M$0.00M$0.00M$0.07M$0.03M
Interest Expense$6.41M$5.30M$6.96M$0.34M$0.00M
Income Before Tax($31.17M)($10.91M)($12.39M)($9.95M)($0.66M)
Income Tax Expense$0.01M$0.00M($0.09M)$0.68M$0.03M
Net Income($31.14M)($10.91M)($12.30M)($10.63M)($0.64M)
Net Margin %(computed)-143.14%-49.71%-151.44%-215.47%-46.70%
Per Share & EBITDA
EPS (Basic)$-0.33$-0.14$-0.20$-0.17$-0.23
Wtd Avg Shares95.69M78.59M61.62M61.53M2.74M
EBITDA($22.83M)($4.35M)($4.45M)($8.93M)($0.60M)
EBITDA Margin %(computed)-104.93%-19.83%-54.75%-180.99%-43.92%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Item 9 Labs Corp.

关于Item 9 Labs Corp.(INLB)损益表

Item 9 Labs Corp.(INLB)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,INLB实现营收$0.02B,毛利润$0.01B(毛利率33.61%),净利润($0.03B)(净利率-143.14%)。

常见问题

INLB · 4 问

Item 9 Labs Corp.(INLB)2022财年营收为$0.02B,同比down0.8%。

INLB revenueINLB salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09